Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
lidocaine hydrochloride 1.5% (300 mg/20 mL) + adrenaline (epinephrine) 1 in 200 000 (100 microgram/20 mL) injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
epinephrine 50 microgram / 5 mL + lidocaine hydrochloride 50 mg / 5 mL injection, 5 mL ampoule (medicinal product unit of use) |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
lidocaine hydrochloride 1% (200 mg/20 mL) + adrenaline (epinephrine) 1 in 200 000 (100 microgram/20 mL) injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
insulin glargine 100 units/mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
lidocaine hydrochloride 2% (100 mg/5 mL) + adrenaline (epinephrine) 1 in 80 000 (62.5 microgram/5 mL) injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
insulin glargine 100 units/mL injection, cartridge |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
lidocaine hydrochloride 0.4% (2 g/500 mL) + glucose 5% (25 g/500 mL) injection, bag |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
lidocaine hydrochloride 2% (44 mg/2.2 mL) + adrenaline (epinephrine) 1 in 80 000 (27.5 microgram/2.2 mL) injection, cartridge |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
lidocaine hydrochloride 2% (44 mg/2.2 mL) + adrenaline (epinephrine) 1 in 100 000 (22 microgram/2.2 mL) injection, cartridge |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
lidocaine (lignocaine) hydrochloride 2% (36 mg/1.8 mL) + adrenaline (epinephrine) 1 in 80 000 (27.5 microgram/1.8 mL) injection, cartridge |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
epinephrine 100 microgram / 20 mL + lidocaine hydrochloride 100 mg / 20 mL injection, 20 mL vial (medicinal product unit of use) |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
busulfan 60 mg/10 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
metaraminol 10 mg/mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
busulfan 60 mg/10 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
lidocaine hydrochloride 2% (400 mg/20 mL) + adrenaline (epinephrine) 1 in 200 000 (100 microgram/20 mL) injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
tacrolimus 5 mg/mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
ganirelix 250 microgram/0.5 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
betamethasone (as sodium phosphate) 2.96 mg/mL + betamethasone (as acetate) 2.71 mg/mL injection, ampoule |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
gadobenate dimeglumine 7.935 g/15 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
gadobenate dimeglumine 10.58 g/20 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
gadobenate dimeglumine 2.645 g/5 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
parecoxib 40 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
Calcium Folinate (Ebewe) 1 g/100 mL injection, 100 mL vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
testosterone propionate 20 mg/mL + testosterone phenylpropionate 40 mg/mL + testosterone isocaproate 40 mg/mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
gadobenate dimeglumine 5.29 g/10 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
ketamine 200 mg/2 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
vinorelbine 50 mg/5 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
cytarabine 500 mg / 5 mL injection, 5 mL vial (medicinal product unit of use) |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
edetate calcium disodium 1 g/5 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
ceftazidime 1 g injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
vinorelbine 10 mg/mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
cytarabine 1 g/10 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
edetate disodium 30 mg/mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
nandrolone decanoate 50 mg/mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
cytarabine 100 mg/5 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
sodium thiosulfate pentahydrate 25% (12.5 g/50 mL) injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
cytarabine 100 mg/mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
sodium thiosulfate pentahydrate 25% (2.5 g/10 mL) injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
cytarabine 2 g/20 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
ceftazidime 2 g injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
metronidazole 500 mg/100 mL injection, bag |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
cytarabine 500 mg/25 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
levetiracetam 500 mg/5 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
influenza trivalent adult vaccine 2009 injection, 0.5 mL syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
influenza trivalent child vaccine 2009 injection, 0.25 mL syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
imiglucerase 400 units injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
imiglucerase 200 units injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
metronidazole 0.5% (500 mg/100 mL) injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
buprenorphine 300 microgram/mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
dicloxacillin 1 g injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
hydralazine hydrochloride 20 mg injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
dicloxacillin 500 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
calcitriol 1 microgram/mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
calcitriol 2 microgram/mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
human papillomavirus (type 16) vaccine 20 microgram + human papillomavirus (type 18) vaccine 20 microgram injection, 0.5 mL syringe |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
ornipressin 5 units/mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
pentamidine isetionate 300 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
pertuzumab 420 mg/14 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
lincomycin 600 mg/2 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
bivalirudin 250 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
bupivacaine hydrochloride 0.125% (25 mg/20 mL) + fentanyl 100 microgram/20 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
methadone hydrochloride 10 mg/mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
bupivacaine hydrochloride 25 mg / 20 mL + fentanyl 100 microgram / 20 mL injection, 20 mL ampoule (medicinal product unit of use) |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
foscarnet sodium 6 g/250 mL injection, bottle |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
bupivacaine hydrochloride 0.125% (250 mg/200 mL) + fentanyl 1000 microgram/200 mL injection, bag |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
noradrenaline (norepinephrine) 1 in 1000 (2 mg/2 mL) injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
magnesium chloride 480 mg/5 mL injection, ampoule |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
methadone hydrochloride 10 mg/mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
ropivacaine hydrochloride monohydrate 200 mg/100 mL + fentanyl 400 microgram/100 mL injection, bag |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
ropivacaine hydrochloride monohydrate 400 mg/200 mL + fentanyl 400 microgram/200 mL injection, bag |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
ropivacaine hydrochloride monohydrate 200 mg/100 mL + fentanyl 200 microgram/100 mL injection, bag |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
ropivacaine hydrochloride monohydrate 400 mg/200 mL + fentanyl 800 microgram/200 mL injection, bag |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
succinylated gelatin 20 g / 500 mL injection, 500 mL bottle (medicinal product unit of use) |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
rituximab 100 mg/10 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
succinylated gelatin 40 g/L injection, bottle |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
rituximab 500 mg/50 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
succinylated gelatin 40 g/L injection, bag |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
succinylated gelatin 20 g/500 mL injection, bag |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
thiamine nitrate 3.1 mg + riboflavin 3.6 mg + nicotinamide 40 mg + pyridoxine 4 mg + pantothenic acid (as sodium pantothenate) 15 mg + ascorbic acid 100 mg + biotin 60 microgram + folic acid 400 microgram + cyanocobalamin 5 microgram injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
influenza trivalent adult vaccine 2013 injection, 0.5 mL syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
human papillomavirus (type 6) vaccine 20 microgram + human papillomavirus (type 11) vaccine 40 microgram + human papillomavirus (type 16) vaccine 40 microgram + human papillomavirus (type 18) vaccine 20 microgram injection, 0.5 mL vial |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
A/California/7/2009 (H1N1)-like strain (A/California/7/2009 (NYMC X-181)) 9 microgram + A/Victoria/361/2009 (H3N2)-like strain (A/Victoria/361/2011 (IVR-165)) 9 microgram + B/Wisconsin/1/2010-like strain (B/Hubei-Wujiagang/158/2009 (NYMC BX-39)) 9 microgram injection, 0.1 mL syringe (medicinal product unit of use) |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
influenza trivalent child vaccine 2013 injection, 0.25 mL syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
human papillomavirus (type 6) vaccine 20 microgram + human papillomavirus (type 11) vaccine 40 microgram + human papillomavirus (type 16) vaccine 40 microgram + human papillomavirus (type 18) vaccine 20 microgram injection, 0.5 mL syringe |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
ceftaroline fosamil 600 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
doxorubicin hydrochloride (as pegylated liposomal) 20 mg/10 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
fluorescein 500 mg/5 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
meningococcal group C polysaccharide vaccine 10 microgram/0.5 mL injection, syringe |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
doxorubicin hydrochloride (as pegylated liposomal) 50 mg/25 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
fluorescein sodium 500 mg/5 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
ustekinumab 45 mg/0.5 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
ustekinumab 90 mg/mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
ustekinumab 45 mg/0.5 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
ceftriaxone 1 g injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
lanreotide 90 mg injection, syringe |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
ceftriaxone 2 g injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
lanreotide 60 mg injection, syringe |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
calcium chloride dihydrate 1 g/10 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
fludarabine phosphate 50 mg/2 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
lanreotide 120 mg injection, syringe |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
calcium chloride dihydrate 1 g/10 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|